Literature DB >> 7737987

Structural basis for the biological activities of bovine seminal ribonuclease.

J S Kim1, J Soucek, J Matousek, R T Raines.   

Abstract

Bovine seminal ribonuclease (BS-RNase) is a homolog of RNase A with special biological properties that include specific antitumor, aspermatogenic, and immuno-suppressive activities. Unlike RNase A, BS-RNase is a dimer cross-linked by disulfide bonds between Cys31 of one subunit and Cys32 of the other. At equilibrium, this dimer is a mixture of two distinct quaternary forms, M = M and M x M. The conversion of M = M to M x M entails the exchange of NH2-terminal alpha-helices between subunits. Here, the cytotoxic activities of purified M x M were shown to be greater than those of purified M = M, despite extensive equilibration of M = M and M x M during the time course of the assays. Replacing Cys31 or Cys32 with a serine residue did not compromise the enzymatic activity of dimeric BS-RNase, but reduced both the fraction of M x M at equilibrium and the cytotoxicity. We conclude that the M x M form is responsible for the special biological properties of BS-RNase. Since cytosolic ribonuclease inhibitor binds tightly to monomeric but not dimeric BS-RNase and only the M x M form can remain dimeric in the reducing environment of the cytosol, we propose that BS-RNase has evolved its M x M form to retain its lethal enzymatic activity in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737987     DOI: 10.1074/jbc.270.18.10525

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Second generation antitumour human RNase: significance of its structural and functional features for the mechanism of antitumour action.

Authors:  S Di Gaetano; G D'alessio; R Piccoli
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

2.  Mutation of cysteine 171 of pestivirus E rns RNase prevents homodimer formation and leads to attenuation of classical swine fever virus.

Authors:  Birke Andrea Tews; Eva-Maria Schürmann; Gregor Meyers
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

3.  Secretory ribonucleases are internalized by a dynamin-independent endocytic pathway.

Authors:  Marcia C Haigis; Ronald T Raines
Journal:  J Cell Sci       Date:  2003-01-15       Impact factor: 5.285

4.  Dimer formation by a "monomeric" protein.

Authors:  C Park; R T Raines
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

Review 5.  The RNase a superfamily: generation of diversity and innate host defense.

Authors:  Kimberly D Dyer; Helene F Rosenberg
Journal:  Mol Divers       Date:  2006-11       Impact factor: 2.943

6.  Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variant.

Authors:  Antonello Merlino; Giovanna Avella; Sonia Di Gaetano; Angela Arciello; Renata Piccoli; Lelio Mazzarella; Filomena Sica
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

7.  Ribonuclease A variants with potent cytotoxic activity.

Authors:  P A Leland; L W Schultz; B M Kim; R T Raines
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 8.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

9.  Human ribonuclease 4 (RNase 4): coding sequence, chromosomal localization and identification of two distinct transcripts in human somatic tissues.

Authors:  H F Rosenberg; K D Dyer
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

Review 10.  Ribonucleases as potential modalities in anticancer therapy.

Authors:  Wojciech Ardelt; Barbara Ardelt; Zbigniew Darzynkiewicz
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.